Navigation Links
VYVANSE(TM) Drug for the Treatment of ADHD in Adults

PHILADELPHIA, Pennsylvania, Shire plc announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for VYVANSE(TM) (lisdexamfetamine dimesylate) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults. This application is subject to a 10-month FDA review period.

"ADHD is a treatable disorder that affects adults as well as children," said Matthew Emmens, Shire Chief Executive Officer. "We are pleased with the results of VYVANSE studies conducted in adults and we believe this product will meet an important need in the adult ADHD marketplace. VYVANSE is a priority in our ADHD portfolio and we are committed to developing this next generation ADHD medication so that adults diagnosed with ADHD may benefit from treatment with VYVANSE."

VYVANSE is a prodrug stimulant that is therapeutically inactive until metabolized in the body and active d-amphetamine is released. VYVANSE is different from other oral long acting stimulants of amphetamine and methylphenidate that rely on delivery systems which may be affected by pH and GI transit time.

Shire plans to announce full results from its phase III clinical trial for the treatment of ADHD in adults at a major scientific conference in Q4 2007.

The FDA approved VYVANSE on February 23, 2007, to treat symptoms of ADHD in children aged 6 to 12. Additional information about VYVANSE and Full Prescribing Information are available at www.vyvanse.com.

About ADHD

Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). ADHD is one of the most common psychiatric disorders in children and adolescents. The disorder is also estimated to affect approximately 9.8 million adults across the U.S. ba
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: VYVANSE Drug for the Treatment ADHD Adults

(Date:12/3/2009)... According to the World Health Orga...ne Flu") has reached a pandemic level. Over 500,0...st 6,500 fatalities. Since there is no longer a r...ese numbers undoubtedly understate the real situat...bin/prnh/20091203/NY20654 ) ,, There are curre...
(Date:12/3/2009)...ewswire/ -- An exciting treatment gaining acceptan...elet-rich plasma therapy (PRP), is showing strong ...t procedures, according to a prominent dental rese...logy . ,, James Rutkowski, DMD, PhD, reported...erican Academy of Implant Dentistry that platelet-...
(Date:12/3/2009)...ew cases created by a single case of H1N1 influenz...cination, social distancing and the use of antivir...e virus, suggests an epidemiological modelling stu... reported in CMAJ ( Canadian Medical Associati...at data from laboratory-confirmed cases of H1N1 be...
(Date:12/3/2009)... World Medical, a leading global healthcare compan...e, announced that international medical quality au...al Quality Advisory Board (MQAB). , ...–- Satori World Medical, a leading global he...cal travel space, announced that international med...
(Date:12/3/2009)...due in those who rise and smoke, , , TH...igarette first thing in the morning? If so, take n...smoke inhale more nicotine than other smokers. ,...the researchers said he thinks it could be a sign ...rags on their cigarettes. And that, he said, could...
Breaking Medicine News(10 mins):Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Early Morning Smokers May Be More Dependent on Nicotine 2
... ),a leader in radiology and medical image and inf...t executives of AMICAS are scheduled to,address in...onference 2008,being held in Boston, MA., (Log...y at 10:20 a.m. (Eastern Time), 9:20 a.m. (Cent...
...dents with type 1 diabetes have been restored to f...other than insulin by scientists at UT Southwester...in in 1922, type 1 diabetes (insulin-dependent dia...earchers, which appear online and in a future issu...
...th,anniversary during a special program for employ... event featured HCA Co-Founder and Chairman Emerit..., Jack O. Bovender, Jr., who spoke about,HCA,s fou...CA,s annual Caring for the Community employee givi...
...World Congress for Interventional Therapies for Ty...und the world will convene in an exchange with lea...emerging new therapies for type 2 diabetes. , Twe...iscussion of all aspects of this emerging discipli...
...Guests in Connection with the ...NVER, Aug. 25 Emdeon Business,Services, a leading...,communication solutions, announced today its role...resident of Corporate Strategy, Miriam J.,Paramore...
... list ,Judgment Free Zone, rakes in revenu...itness, the health club,chain known for its "Judgm...he top spot among all fitness companies on Inc. ma...LOGO ), The Inc. 5,000 list ranks companies acco...
Other Medicine News:Health News:AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2008 2Health News:UT Southwestern scientists discover leptin can also aid type 1 diabetics 2Health News:UT Southwestern scientists discover leptin can also aid type 1 diabetics 3Health News:HCA Celebrates 40th Anniversary 2Health News:Endocrinologists and surgeons join forces to fight type 2 diabetes 2Health News:Nashville's Emdeon Business Services to Co-Sponsor Democratic National Convention Health Policy Event 2Health News:N.H.-Based Health Club Operator Sets The Industry's Pace 2
(Date:12/3/2009)...PLE GROVE, Minn., Dec. 3 Upsher-Sm...ase of its strategic plan for central nervous syst...piramate), an internally developed program for the... with Upsher-Smith,s proprietary formulation techn... early 2010 for the adjunctive treatment of epilep...
(Date:12/3/2009)...BURG, Pa., Dec. 3 New s...rocessing company build a new cold storage facilit...or expand operations while creating at least 20 jo..., The Pennsylvania Industrial Development Author...three projects. The investments, in the form of lo...
(Date:12/3/2009)...LZE, Germany, Dec. 3 Honeywell (NY...ion agreement with Pro-Lab Laboratuar Teknolojiler... Jackson® high-purity solvents in Turkey. ,...vely by biotechnology and pharmaceutical companies..., "The annual growth rate of the Turkish pharmace...
Breaking Medicine Technology:Upsher-Smith Announces Milestone in Development of CNS Strategy 2Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 60047 1Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 60047 2Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 60047 3IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant wins first BayCare Quality Award 60044 1IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant wins first BayCare Quality Award 60044 2IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant wins first BayCare Quality Award 60044 3Latest analysis confirms suboptimal vitamin D levels in millions of US children 10517 1Latest analysis confirms suboptimal vitamin D levels in millions of US children 10517 2
...eduction in sedation during the,early post-operati...ignificant reduction in nausea in the female,patie..., 8th June 2007 - CeNeS Pharmaceuticals plc (AIM:,...y, announces,additional data from post-hoc analysi...orphine-6-glucuronide) in over 500 patients,with p...
...RE)--Jun 8, 2007 - ProEthic,Pharmaceuticals, Inc.,...ny that acquires, develops, licenses, and markets ...led Phase III study,data for PRO-513, the Company,...headaches. The results were presented in two poste... 49th Annual,Scientific Meeting in Chicago by Rich...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 2ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 3ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 4
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: